Quantitative Systems Pharmacology Model Predicts Combination Activity of CD19-Targeted Loncastuximab Tesirine Codosed With a CD20/CD3 T-cell Bispecific (Epcoritamab) in Diffuse Large B-cell Lymphoma
Email this document.
Enter your email address below to send this document.